Thermo Fisher Scientific’s state-of-the-art sterile drug development and manufacturing facility in Singapore supports rapid fill finish vaccines and other therapeutics for an expanding biopharma market.
With support from the Singapore Economic Development Board, (EDB) this facility is an essential part of Thermo Fisher Scientific’s global network – now comprising of six facilities supporting aseptic manufacturing and sterile fill finish.
Our commitment to meeting scientists’ needs globally is further strengthened by this facility, which is designed to enhance our network for biomedical research, development, and commercialization.
DELIVERED
WITH
WITH
AGILITY & INTEGRITY
